2002-2003
The following is a description of a study from one of the many researchers that our organization has funded.
The role of DRAK2, a lymphoid-enriched apoptotic nuclear DAP-like kinase, in T cell activation and autoimmunity
Craig Walsh, Ph.D.
University of California
Irvine, California
Dr. Walsh’s study is aimed at understanding the basic mechanisms that prevent inappropriate lymphocyte activation in autoimmune diseases, such as rheumatoid arthritis. He has identified a gene, DRAK2, which normally inhibits T cell activation (which causes the inflammatory response). Should this study establish a link between DRAK2 and RA, this gene may serve as a target for clinical intervention.
You may return to the list of research that we have funded.
